Rice University launches online programming for entrepreneurs dealing with COVID-19 closures

biz ed

Rice University will launch online classes next week for small business leaders planning their recovery. Courtesy of Rice University

Houston small businesses and startups have a long road of recovery ahead of them, and Rice University and some of its partners want to help local entrepreneurs prepare for it.

Rice University's Susanne M. Glasscock School of Continuing Studies has partnered with the Ion — along with the Center for Houston's Future and Rice Alliance for Technology and Entrepreneurship — to launch the Back In Business Initiative. The program will begin with three courses in the week of April 20 to 24. The three courses are:

"Glasscock's mission has always been to provide education to the residents of Houston," says Robert Bruce, dean of the Glasscock School, in a news release. "We specialize in providing responsive, practical information that will help our constituents when and how they need it most. To assist our struggling Houston small business community during this crisis, we created this trilogy of courses to help analyze their current situation, use creative problem-solving and provide meaningful communications to help them weather this situation."

More classes will be added as needed. The classes have a $25 registration fee, and anyone can enroll online.

"Today's health crisis may have changed many aspects of our daily lives, but it has not affected our commitment to providing the right tools and education to help our community succeed," says Jan Odegard, senior director of academic and industry partnerships at the Ion, in the release. "We all have a role to play in meeting the challenge of COVID-19 and we are excited to be partnering with the Glasscock School of Continuing Studies to support Houston small businesses in this time of uncertainty."

The university also touts OpenRICE as a resource for businesses. The online education platform is available to the Houston community for free. Rice also has a 20 percent discount for all professional studies courses and programs enrollment — with the ability to postpone for up to a year without a fee. This deal runs through April 30.

Rice University's Glasscock school of Continuing Studies is the Ion's first academic partnership to be announced. Courtesy of Rice University

The Ion names inaugural academics partner, course programming for Houston hub

Teaming up

A burgeoning entrepreneurship hub has taken a major step forward in its development with the announcement of its first academic partner and coursework for the partnership.

The Ion has teamed up with Rice University's Glasscock School of Continuing Studies to bring programming to the to-be hub, which is expected to open in early 2021.

"We are thrilled to extend our programming to the Ion constituents and Houston's innovation ecosystem," says Robert Bruce Jr., dean of Rice's Continuing Studies school, in a news release. "Continuing education, whether that takes the form of an advanced certificate or a single course, is an important part of the innovation lifecycle, and we are excited to provide this to Houston's entrepreneurs."

The school will offer a mix of online and hybrid courses and certificate programs for personal and professional development. Select courses are slated to begin on January 13, and sign-ups for the courses are live online.

"We know business leaders have many goals and responsibilities and we look forward to supporting them to achieve new levels of success through our responsive and proven programming," Bruce adds.

Some of the first semesters programming is expected to focus on computer and data science education, corporate financial planning, leadership courses, project management, and more, according to the release. Mary Lynn Fernau, the Glasscock School's director of executive and international programs, will manage the partnership.

"As The Ion seeks to increase access to flexible career development in tech and entrepreneurial programming, our partnership with the Glasscock School serves as a model for what professional activation at The Ion can look like at its best," says Gabriella Rowe, executive director of The Ion, in the release.

Trilogy Education and Rice University have joined forces for a new program. Photo courtesy of Rice University

Rice University teams up with workforce accelerator to create a first-of-its-kind fintech bootcamp

Back to school

As Rice University's campus continues to welcome back its students for a new year, the administration has big news about a new, innovative program to share.

Rice University's Glasscock School of Continuing Studies has partnered with New York-based workforce accelerator, Trilogy Education, to provide the first fintech boot camp on a college campus, according to a representative from the company.

"Technology skills are becoming foundational for many roles in the finance, energy and life science sectors," says David Vassar, assistant dean of professional and executive programs at the Glasscock School, in a news release. "We have partnered with Trilogy Education to bring to market a boot camp that prepares students to use their technical skills in a wide variety of fintech applications, from robo-advising to cryptocurrency. Whether you are already in finance or are looking for a way to transition into the industry, this program will prepare you to build a meaningful career in the fast-moving world of fintech."

Rice University FinTech Boot Camp is a 24-week program, and the inaugural class began in July. Enrollment for the next round is open from now until November 18. The program will provide students with core coding languages and technical tools that are crucial in the industry as well as pertinent technologies like machine learning and cryptocurrency. The participants will also have career-planning services and will receive a Certificate in Financial Technology from Rice.

The financial industry is booming in Houston, per the release, and companies are in competition for trained talent. Institutions like U.S. Bancorp and JPMorgan Chase have more coding positions open than Apple and Google, the release reveals, and according to data from Burning Glass, the country has added over 1.5 million fintech jobs in the past 8 years.

"The Rice University FinTech Boot Camp comes at a critical moment of need as the city of Houston transforms itself into a national hub for enterprise technology," says Robert Bruce, dean of the Glasscock School, in the release. "We've seen several fintech companies choose Houston to open new office locations and a rising demand from our longstanding industries like energy and manufacturing to transform themselves into technology and data-driven businesses."

Last year, the school launched its first boot camp in partnership with Trilogy. The Rice University Data Analytics Boot Camp has recently grown to expand to a new location in the Energy Corridor, the release states.

"Rice University's Glasscock School of Continuing Studies is playing an important role in building the digitally skilled workforce that Houston needs to support a growing innovation economy," says Dan Sommer, CEO and founder of Trilogy Education, in the release. "The Rice University FinTech Boot Camp will help working adults in Houston capitalize on the exploding demand for technology and data skills and spur additional investment in fintech throughout the region."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

CPRIT CEO: Houston’s $2B in funding is transforming cancer research and prevention

fighting cancer

With its plethora of prestigious health care organizations like the University of Texas MD Anderson Cancer Center, UTHealth Houston, and the Baylor College of Medicine, Houston sits at the heart of cancer research and prevention in Texas.

Of course, it takes piles of cash to support Houston’s status as the state’s hub for cancer research and prevention. Much of that money comes from the Cancer Prevention and Research Institute of Texas (CPRIT).

Data supplied by CPRIT shows organizations in Harris County gained $2.3 billion in institute funding from 2009 through 2025, or nearly $145 million per year. That represents almost 60 percent of the roughly $4 billion that CPRIT has granted to Texas institutions over a 16-year period.

“The life sciences ecosystem that has developed and changed in Houston is phenomenal,” Kristen Doyle, who became the agency’s CEO in July 2024, tells InnovationMap. “In the next decade, we will look back and see a great transformation.”

That ecosystem includes more than 1,100 life sciences and biotech companies, according to the Greater Houston Partnership.

Houston plays critical role in clinical trials

Texas voters approved the creation of CPRIT in 2007. Twelve years later, voters agreed to earmark an extra $3 billion for CPRIT, bringing the state agency’s total investment in cancer research and prevention to $6 billion.

To date, CPRIT money has gone toward recruiting 344 cancer researchers to Texas (mainly to Houston) and has supported cancer prevention services for millions of Texans in the state’s 254 counties. CPRIT funding has also helped establish, expand, or relocate 25 cancer-focused companies. In Houston, MD Anderson ranks as the No. 1 recipient of CPRIT funding.

Regarding cancer research, Doyle says Houston plays a critical role in clinical trials.

“[Clinical trials are] something that CPRIT has focused on more and more. Brilliant discoveries are crucial to this whole equation of solving the cancer problem,” Doyle says. “But if those brilliant ideas stay in the labs, then we’ve all failed.”

Researchers conduct more clinical trials in Houston than anywhere else in the U.S., the Greater Houston Partnership says.

Doyle, a 20-year survivor of leukemia, notes that a minority of eligible patients participate in clinical trials for cancer treatments, “and that’s one of the reasons that it takes so long to get a promising drug to market.”

An estimated 7 percent of cancer patients sign up for clinical trials, according to a study published in 2024 in the Journal of Clinical Oncology.

MD Anderson takes on cancer prevention

Doyle also notes that Houston is leading the charge in cancer prevention.

“We get some national recognition for programs that have been developed in Houston that then can be replicated in other parts of the country,” she says.

Much of the work in Houston focusing on cancer prevention takes place at MD Anderson. The hospital reports that it has received more than $725 million from the CPRIT since 2007, representing approximately 18 percent of CPRIT’s total awards.

“These efforts can have profound impact on the lives of patients and their families, and this funding ensures our exemplary clinicians and scientists can continue working together to drive breakthroughs that advance our mission to end cancer,” Dr. Giulio Draetta, chief scientific officer at MD Anderson, said in a November news release, following the most recent CPRIT award for the hospital totalling more than $29 million.

CPRIT funding for Houston institutions supplements the more than $4.5 billion in federal funding for health and life sciences research and innovations that the Houston area received from 2020 to 2024, according to the Greater Houston Partnership.

“We are curing cancer every single day,” Doyle says of CPRIT. “Every step that we are taking — whether that’s funding great ideas or funding the clinical trials that are bringing promising drugs to Texas and to the world — we are making a difference.”

Houston energy tech co. breaks ground on low-cost hydrogen pilot plant

Coming Soon

Houston’s Lummus Technology and Advanced Ionics have broken ground on their hydrogen pilot plant at Lummus’ R&D facility in Pasadena, Texas.

The plant will support Advanced Ionics’ cutting-edge electrolyzer technology, which aims to deliver high-efficiency hydrogen production with reduced energy requirements.

“By demonstrating Advanced Ionics’ technology at our state-of-the-art R&D facility, we are leveraging the expertise of our scientists and R&D team, plus our proven track record of developing breakthrough technologies,” Leon de Bruyn, president and CEO of Lummus, said in a news release. “This will help us accelerate commercialization of the technology and deliver scalable, cost-effective and sustainable green hydrogen solutions to our customers.”

Advanced Ionics is a Milwaukee-based low-cost green hydrogen technology provider. Its electrolyzer converts process and waste heat into green hydrogen for less than a dollar per kilogram, according to the company. The platform's users include industrial hydrogen producers looking to optimize sustainability at an affordable cost.

Lummus, a global energy technology company, will operate the Advanced Ionics electrolyzer and manage the balance of plant systems.

In 2024, Lummus and Advanced Ionics established their partnership to help advance the production of cost-effective and sustainable hydrogen technology. Lummus Venture Capital also invested an undisclosed amount into Advanced Ionics at the time.

“Our collaboration with Lummus demonstrates the power of partnerships in driving the energy transition forward,” Ignacio Bincaz, CEO of Advanced Ionics, added in the news release. “Lummus serves as a launchpad for technologies like ours, enabling us to validate performance and integration under real-world conditions. This milestone proves that green hydrogen can be practical and economically viable, and it marks another key step toward commercial deployment.”

---

This article originally appeared on EnergyCapitalHTX.com.

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.

View All Listings